A Registry Study of Biomarkers in Heart Valve Disease
Valvular Heart Disease, impacting 2.5% of the population, is predominantly observed in the elderly and is on the rise. The primary conditions within this category are Aortic Stenosis and Mitral Regurgitation. These conditions are linked to considerable morbidity and mortality, presenting a formidable challenge in optim
| Condition(s) | Cardiovascular Diseases |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | Valvular Heart Disease, impacting 2.5% of the population, is predominantly observed in the elderly and is on the rise. The primary conditions within this category are Aortic Stenosis and Mitral Regurgitation. These conditions are linked to considerable morbidity and mortality, presenting a formidable challenge in optimizing treatment strategies. Pathophysiology of Valvular Heart Disease remains poorly known. The aim of the present study is to identify biomarkers involved in this disease using multi-omics approaches |
| Who can participate | Inclusion Criteria: * Patients clinically diagnosed with heart valve disease in Beijing Anzhen Hospital Exclusion Criteria: * Age \< 18 years * Failure to obtain medical records and ultrasound data * Refuse follow-up |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Beijing Institute of Heart, Lung and Blood Vessel Diseases |
| Locations | Beijing, Beijing Municipality, China |
| Start date | 2016-01-01 |
| NCT ID | NCT06223906 |
| Official listing | https://clinicaltrials.gov/study/NCT06223906 |